China Universal Asset Management »

Kiniksa Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $72k 4.1k 17.57
2023-09-30 $16k 911 17.56
2023-06-30 $6.0k 458 13.10
2023-03-31 $5.0k 468 10.68
2022-12-31 $5.0k 351 14.25
2022-09-30 $4.0k 323 12.38

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Vertex Pharmaceuticals Common Stock (VRTX)
Adobe Common Stock (ADBE)
Nvidia Corp Common Stock (NVDA)
Meta Platforms Inc-class A Common Stock (META)
Servicenow Common Stock (NOW)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Gilead Sciences Common Stock (GILD)
Tesla Common Stock (TSLA)
Visa Inc-class A Shares Common Stock (V)
Workday Inc-class A Common Stock (WDAY)
Alphabet Inc-cl A Common Stock (GOOGL)
Salesforce Common Stock (CRM)

View all positions for China Universal Asset Management

Top funds holding Kiniksa Pharmaceuticals

Vanguard Group
Fairmount Funds Management
Baker Bros. Advisors
Goldman Sachs Group
Arrowpoint Asset Management
Rice Hall James & Associates
Tang Capital Management
Caption Management
Altitude Crest Partners
Millennium Management
Dimensional Fund Advisors
GMT Capital Corp
Walleye Trading Advisors
D. E. Shaw & Co
Connor, Clark & Lunn Investment Management

View all funds holding Kiniksa Pharmaceuticals